Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Covid-19, Acute Myocardial Infarctions and Strokes in France (COVUSI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04542083
Recruitment Status : Not yet recruiting
First Posted : September 9, 2020
Last Update Posted : September 9, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier

Brief Summary:

The COVID-19 pandemic has had dramatic effects on health systems and on non-COVID health care.

Using French inpatient claims data and retrospectively collected clinical data, the investigators will assess the changes in hospital admissions for acute cardiovascular and neurovascular conditions in France during and after the national lockdown.


Condition or disease
COVID-19 Acute Cardiovascular Condition Acute Neurovascular Condition Stroke Acute Myocardial Infarction

Layout table for study information
Study Type : Observational
Estimated Enrollment : 4000 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Impact of COVID-19 on Unplanned Admissions for Acute Cardiovascular and Neurovascular Conditions in France
Estimated Study Start Date : December 1, 2020
Estimated Primary Completion Date : June 1, 2021
Estimated Study Completion Date : June 30, 2021

Group/Cohort
COVID-19 period
Admissions from January to December 2020
Control period
Admissions from January 2018 to December 2019



Primary Outcome Measures :
  1. Daily number of admissions for acute cardio- and neurivascular conditions in France. [ Time Frame: 1 day ]
    Daily number of admissions for acute cardio- and neurivascular conditions in France.


Secondary Outcome Measures :
  1. Specific mortality rate. [ Time Frame: 1 day ]
    Specific mortality rate.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
General population
Criteria

Inclusion criteria:

- Adults admitted in 2018, 2019 or 2020 in a French hospital for acute coronary syndrom or stroke

Exclusion criteria:

- None


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04542083


Contacts
Layout table for location contacts
Contact: Grégoire Mercier, PU PH 4 67 33 91 09 ext 33 g-mercier@chu-montpellier.fr

Locations
Layout table for location information
France
Uh Montpellier
Montpellier, France, 34295
Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Layout table for investigator information
Principal Investigator: Grégoire Mercier, PU PH University Hospital, Montpellier
Layout table for additonal information
Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT04542083    
Other Study ID Numbers: RECHMPL20_0513
First Posted: September 9, 2020    Key Record Dates
Last Update Posted: September 9, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: NC

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Myocardial Infarction
Infarction
Disease
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases